Axovant Rises After Tuesday's Plunge - Biotech Movers
Axovant shares were up in premarket trading on Sept. 27 after plummeting on Tuesday on the heels of the announcement that the company's Phase 3 study of intepirdine in patients with Alzheimer's disease did not achieve its co-primary efficacy endpoints.
These Two Biotech Stocks Are Going Berserk on Wednesday
And then there is Mylan.
Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez
Cempra, Blueprint Medicines and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Monday.
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.